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The effects of 8-bromoguanosine 3’:5’-cyclic monophosphate (8-Br cGMP) on intracellular free calcium con- 
centrations ([Ca”]i) in cultured rat aortic vascular smooth muscle cells (VSMCs) loaded with fura- were 
recorded microfluorometrically. Irrespective of whether VSMCs were at rest (in 5 mM K+ PSS), under Ca2+ 
depletion (in Ca*+-free medium for 10 min) and K+ depolarization (in high K+ PSS), [Ca2+]i was actively 
reduced and reached a new and lower steady-state level with the application of 8-Br cGMP. This may be 
the first and direct evidence that cGMP, a putative mediator of various vasodilators, actively reduces [Ca2+]i 
in VSMCs. 
8-Bromo cyclic GMP; Fura-2; (Vascular smooth muscle cell) 
1. INTRODUCTION 
Although the relaxation of VSMCs induced by 
vasodilators such as nitrocompounds, atria1 
natriuretic peptide and endothelium-dependent 
vasodilators is accompanied by an increase in 
cGMP concentrations [l-4], the underlying 
mechanism mediating this vasorelaxant effect has 
not been clearly defined. Possible mechanisms pro- 
posed for the VSMCs relaxation by cGMP are as 
follows: (i) cGMP may decrease the availability of 
Ca2+ for the contractile process. It has been pro- 
posed that cGMP reduces [Ca2+]i by acceleration 
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of Ca2+ extrusion through the sarcolemma [4-61, 
inhibition of Ca2+ release from intracellular 
Ca2+-storage sites [7-91 or inhibition of Ca2+ in- 
flux into the cells [7-91. (ii) It has been shown that 
cGMP induces phosphorylation of cGMP- 
dependent protein kinase and dephosphorylation 
of myosin light chain, a process which may lead to 
a reduction in the sensitivity of myofilaments for 
Ca2+ [1,2]. 
Direct evidence to show the effect of cGMP on 
[Ca2+]i in VSMCs has apparently never been 
reported. Using a new technique of microfluoro- 
metry of the Ca2+ -sensitive dye fura-2, we report 
here the successful recording of [Ca2+]i transients 
in VSMCs in primary culture, as induced by a 
membrane-permeable analogue 8-Br cGMP. 
cGMP decreased the [Ca2+]i levels, regardless of 
whether VSMCs were at rest, at K+ depolarization 
or at Ca2+ depletion. 
2. MATERIALS AND METHODS 
Fura-2/AM was purchased from Dotite (Japan), 
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8-Br cGMP and db-CAMP from Sigma (USA) and 
ionomycin from Calbiochem (USA). 
2.1. Loading cells with fura- 
Rat aortic medial VSMCs were cultured as 
described [lo] and the primary cell culture was 
used for all experiments. On days 5-6, just before 
reaching confluence, the cultured cells on Lux 
chamber slides were incubated with growth 
medium containing 5 ,uM fura-2, as the acetoxy 
methyl ester (fura-2/AM) [l 11, for 60 min at 37°C. 
The measurements were performed in PSS at 
25°C. The millimolar composition of the normal 
PSS (pH 7.4 at 25°C) was: 135 NaCl, 5 KCl, 1 
CaC12, 1 MgC12, 5.5 glucose, 10 Hepes. High K+ 
solutions were prepared by replacing NaCl with 
KCl, iso-osmotically. The composition of 
Ca’+-free PSS was the same as for normal PSS, ex- 
cept that it contained 2 mM EGTA instead of 1 
mM CaClz. 
2.2. Microfluorometry of fura- 
We used a fluorescence microscope (model Stan- 
dard 18, Zeiss) equipped with a photon-counting 
system (Zeiss), a water immersion objective system 
(Plan-Neofluor 63, Zeiss), and appropriate com- 
binations of filters (Zeiss and Toshiba), in which 
cells were excited at 380 nm and analysed at 
wavelengths between 470 and 560 nm. The 
lOpm 
Fig. 1. Fluorescence photograph of VSMCs loaded with 
fura- in normal PSS. Excitation wavelength, 380 nm; 
emission wavelength, 470-560 nm. N, nucleus. 
fluorescence intensity in a spot (< 1 pm”) of the 
cytosol 3 pm distant from the nucleus was 
measured using our method [12,13]. Each cell was 
exposed to excitation light, only once, for no 
longer than 2 s to avoid the photobleaching effect 
on the dye. In figs.2 and 3, there was a decrease in 
fluorescence intensity, as deduced from the up- 
ward deflection of the ordinate, because it cor- 
responds to an increase in [Ca2+]i when dye in the 
VSMCs was excited at 380 nm [l 11. Estimation of 
[Ca2+]i was made according to Grynkiewicz et al. 
[l 11. The maximum and minimum levels of 
fluorescence intensity were obtained by 
permeabilizing cells, loaded with fura-2/AM as 
described, with 5 x lo-* M ionomycin in the 
presence of excess Ca2+ (10e3 M) and 10 mM 
EGTA (approx. 10m9 M Ca2+), respectively. 
3. RESULTS AND DISCUSSION 
Fluorescence photographs of VSMCs loaded 
with fura- in normal PSS showed that the specific 
greenish-blue fluorescence of the fura-2. Ca2+ 
complex appeared almost exclusively in the cytosol 
(fig.1). The nucleus was also stained, but with a 
more greenish tint. Stress fibers and the ex- 
tracellular space stained negatively. 
When low4 M 8-Br cGMP was applied to 
VSMCs in normal PSS (5 mM K+), [Ca2+]i 
gradually decreased, and reached a lower steady- 
state level within 12 min, and was maintained as 
long as 8-Br cGMP was present (fig.2A). [Ca’+]i 
recovered to the pre-exposure level at 6 min after 
the removal of 8-Br cGMP from the bathing PSS. 
A typical time course of the effect of the applica- 
tion of 8-Br cGMP on [Ca2+]i of VSMCs under 
Ca2+ depletion is shown in fig.2B. When VSMCs 
were exposed to Ca2+-free PSS containing 2 mM 
EGTA, [Ca’+]i was reduced and reached a low 
steady-state level within 10 min. When these 
Ca’+-depleted VSMCs were subsequently exposed 
to 10m4 M B-Br cGMP, a further decrease in 
[Ca’+]i was observed and [Ca2+]i reached a new 
lower steady-state level. The time course of these 
events was similar to that observed in the presence 
of extracellular Ca’+. This steady-state level re- 
mained unchanged for as long as 8-Br cGMP was 
present. 
One of the most typical time courses of the ef- 
fect of the application of 10m4 M 8-Br cGMP on 
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[Ca’+]i in K+-depolarized VSMCs is shown in 
fig.3A. When VSMCs were exposed to 135 mM K+ 
PSS, [Ca’+]i rapidly increased to a steady state 
within 4 min, and remained at this level for the 
duration of the exposure period. The subsequent 
application of 8-Br cGMP induced a gradual 
decrease in [Ca*+]i, and then [Ca*+]i reached a new 
steady level, within 12 min. When 8-Br cGMP was 
A 
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Fig.2. (A) A typical time course of the cytosolic Fig.3. (A) A typical time course of the cytosolic 
fluorescence of VSMCs induced by the application of fluorescence induced by the application of 10e4 M 8-Br 
10e4 M 8-Br cGMP in normal PSS (0) (0, control cGMP to VSMCs in 135 mM K+ PSS. (B) Dose- 
VSMCs, no application of 8-Br cGMP). (B) A typical dependent effect of 8-Br cGMP on the increased [Ca’+]i 
time course of the cytosolic fluorescence of VSMCs in- induced by various concentrations of extracellular K+ 
duced by the application of 10m4 M 8-Br cGMP to (0, 5 mM K+; l , 30 mm K+; /I, 135 mM K+). 
VSMCs in Ca’+-free media (0) (0, control VSMCs, no Fluorometry was carried out 20 min after the application 
application of 8-Br cGMP in Ca2+-free media). Data are of 8-Br cGMP to cells incubated for 6 min in PSS con- 
means k SD of 5 experiments, and 8 cells were examin- taining various concentrations of K+. Data are means k 
ed in each experiment. SD of 5 experiments. 
washed out in the presence of 135 mM K+, [Ca*+]i 
rapidly rose to a higher level, which was not 
significantly lower than the value observed prior to 
the application of 8-Br cGMP, in the presence of 
135 mM K+. Reductions of [Ca*+]i by 8-Br cGMP 
in VSMCs at rest (in 5 mM K+ PSS) and under 
depolarization (30 mM K+ and 135 mM K+ PSS) 
were dose-dependent (fig.3B). 
IO-‘M B-Br cGMP 
55 c. I.. 1. I I.. I I.. . . ,? 
-8 0 IO al 30 
Time (mini 
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Table 1 lists the levels of [Ca’+]i in VSMCs 
before and 20 min after (at a new and lower steady 
state) the application of 8-Br cGMP, estimated as 
described. The levels of [Ca’+]i at rest and in the 
case of K+ depolarization were similar to those 
noted in studies using either fura- or quin-2 
[14,15]. 
The present study demonstrates that 8-Br 
cGMP, a membrane-permeable analogue of 
cGMP, actively decreases [Ca*+]i of VSMCs in 
primary culture, regardless of whether VSMCs are 
Ca2+-depleted, at rest or in a state of K+ 
depolarization. Thus, 8-Br cGMP decreases 
[Ca2+]i in both Ca’+-depleted and Ca2+- 
overloaded VSMCs. The finding that 8-Br cGMP 
actively reduces [Ca2+]i n Ca2+-depleted VSMCs 
in the absence of extracellular Ca2+ indicates that 
there is an acceleration of Ca2+ extrusion through 
the sarcolemma. This observation provides 
evidence to support the hypotheses that accelera- 
tion of Ca2+ extrusion may induce a decrease in 
[Ca’+]i in VSMCs [4-61. 
As shown in table 1, the higher the [Ca”]i 
before application of 8-Br cGMP, the greater was 
the extent of the decrease in [Ca2+]i in the VSMCs. 
Table 1 
Effects of 10m4 M 8-Br cGMP on [Ca2+]i of VSMCs 
Estimated value of [Ca’+]i (nM) 
State of Before 20 min Extent of the 
VSMCs applica- after [Ca’+]i 
cation applica- decrease 
tion 
(a) (b) (a)-(b) 
Ca2+ depletion 
(in Ca’+-free 
media) 56+ 7 31+ 6 25 
At rest 
(in 5 mM K+ 
PSS) 148 5 12 91 f 10 57 
K’ depolari- 
zation 
(in 30 mM 
K+ PSS) 292+35 128k 11 164 
K+ depolariza- 
tion 
(in 135 mM 
K+ PSS) 553 k 83 176 f 22 377 
Values are means k SD (n = 8) 
Thus, it was suggested that the extent of the [Ca”]r 
decrease induced by 8-Br cGMP depended on the 
level of [Ca2+]i on application of this nucleotide. 
This is consistent with reports that sarcolemmal 
Ca2+-ATPase of VSMCs was stimulated in a dose- 
dependent manner by free concentrations of Ca2+ 
and that the Ca’+-ATPase was accelerated, dose- 
dependently, by nitroglycerin through an increase 
in cGMP levels and activation of cGMP-dependent 
protein kinase [5,6]. Thus, acceleration of the sar- 
colemmal Ca2+-ATPase activity may be involved 
in the [Ca2+]i reduction seen with cGMP. We pro- 
posed that nitroglycerin accelerates the extrusion 
of Ca2+ through the sarcolemma [121. 
The possibility has been discussed that CAMP- 
dependent protein kinase can be activated by 
cGMP, at high concentrations [161. Since the con- 
centrations of 8-Br cGMP used here are relatively 
high, it is possible that the CAMP-dependent 
mechanism may be involved in the reduction in 
[Ca2+]i by 8-Br cGMP in VSMCs [17]. Fig.4 
demonstrates a typical time course observed when 
low4 M db-CAMP was applied to VSMCs in 135 
mM K+ PSS. [Ca”]i elevated by K+ depolarization 
was gradually decreased and reached a lower 
steady-state l vel, within 16 min. It is apparent that 
the extent of [Ca2+]i reduction induced by 10e4 M 
db-CAMP is much less than that induced by 10T4 
M 8-Br cGMP (fig.3A,B). Thus, it was indicated 
that the effects of 8-Br cGMP on the reduction in 
lCi4M db-cAMP 
. 
135 mM K 
6 l 
J”‘~m”“a~‘~“’ 
-8 0 IO 20 
Time (min) 
Fig.4. A typical time course of the cytosolic fluorescence 
observed when 10m4 M db-CAMP was applied to VSMCs 
in 135 mM K+ PSS. Data are means rfr SD of 4 ex- 
periments. 
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[Ca’+]i may be much more potent than those of 
db-CAMP. Furthermore, it was reported that 
cGMP was less than l/200 as effective as CAMP, 
as an apparent competitor of CAMP-dependent 
protein kinase [ 181, and the molar concentration of 
8-Br cGMP required to induce a reducation in 
[Ca’+]i is markedly low (< 10m6 M; ~~0.01, Stu- 
dent’s t-test). Thus, it was suggested that the 
mechanism via a CAMP-dependent system may 
have a less important role in the effects of B-Br 
cGMP on [Ca2+]i of VSMCs, in the present study. 
The present report may be the first to show that 
an increase in intracellular cGMP levels actively 
reduces [Ca2+]i of VSMCs at rest, under conditions 
of K+ depolarization or Ca2+ depletion. The reduc- 
tion in [Ca’+]i through activation of the Ca2+ 
pump is probably one of the major mechanisms in- 
volved in cGMP-mediated vasodilatation. The ef- 
fect of cGMP on the Ca2+ influx through the 
sarcolemma was not evaluated and remained to be 
elucidated in the present study. 
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